A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

NCT05712356 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholangiocarcinoma
Gallbladder Cancer
Gallbladder Carcinoma
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Bile Duct Cancer
Gall Bladder Cancer
Gall Bladder Carcinoma

Interventions

DRUG: certepetide
DRUG: Durvalumab
DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: FOLFOX regimen
DRUG: Placebo

Sponsor

Lisata Therapeutics, Inc.